14 results
Topical drug formulations, comparison and considerations

#pharmacology #table #medications #comparison #drugs #treatment #pharmacotherapy #dermatology
#pharmacology #table ... #medications #comparison ... #drugs #treatment ... #pharmacotherapy ... #dermatology
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
#pharmacology #treatment ... #medications #table ... #pharmacotherapy ... decisionaid #cardiology #hematology ... #warfarin #dosing
FDA-Approved 1st line Medications for Tobacco Cessation Treatment

Nicotine patch, Nicotine lozenge, Nicotine gum, Nicotine inhaler, Nicotine
FDA-Approved 1st line Medications ... Tobacco Cessation Treatment ... Cessation #Therapy #Comparison ... #Table #Agents ... #Dosing
Anti-infective stewardship, including tips for using anti-infectives wisely, criteria for stepdown from IV to PO dosage
including tips for using ... #antibiotics #medications ... #table #treatment ... #drugs #pharmacotherapy
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... Each class of medications ... #pharmacology #pharmacotherapy ... #table #comparison ... endocrinology #treatment
PDE5 inhibitors are usually the drugs of first choice for erectile dysfunction.

PDE5 inhibitors enhance an erection that is
#pharmacology #comparison ... #treatment #medications ... #dosing #drugs ... #table #pharmacotherapy
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
Managing BPD Clinical ... with ‘treatment ... summarised in Tables ... Personality #Disorder #Medications ... Effectiveness #Table
Inpatient Management of Opioid Use Disorder: Methadone vs Buprenorphine - Comparison Table

Some patients may decline buprenorphine
Buprenorphine - Comparison ... Table Some patients ... interested in medication ... assisted treatment ... Dosing usually begins
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
Risk factors: Critical ... : 33% • Treatment ... : No • Treatment ... #diagnosis #comparison ... #table
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Eosinophils < 100 Dosing ... : 250 mcg tablet ... recommendations for the treatment ... the use of this medication ... won’t have any clinical